Resistant infections can lead to higher mortality and are often more expensive to treat than susceptible infections2
of all antibiotics prescribed in European hospitals are inappropriate or unnecessary3
Resistant infections were found to increase excess length of stay (LOS) by 4.9-9.3 days4
“An accurate diagnosis is the first step to getting effective treatment. No one should suffer or die because of a lack of diagnostic services, or because the right tests were not available.”
Beyond the medical and economic burden on the hospital, antimicrobial resistance leads to an organisational burden in the hospital (patient isolation) and administrative burden (reporting).
The challenges lie in patient screening and the implementation of evidence-based practice interventions to enable appropriate target antibiotherapy5.
BD supports you in enhancing compliance to guidelines and offers you safe alternatives to help reduce SSIs, CAUTIs and CRBSIs with a portfolio of solutions which include innovative technologies and services.
BD supports you in improving sample quality by optimising processes and standardising practices with a portfolio of solutions which include innovative technologies and services.
BD supports more rapid, accurate and appropriate diagnostic identification enabling effective clinical decision-making with a portfolio of solutions which include innovative technologies and services.
BD supports you in enabling remote multi-site diagnostic result availability with digital infrastructure for faster decision-making with a porfolio of solutions which include innovative technologies and services.
